Literature DB >> 12839629

Leukocyte esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and in controls.

Per-Anders Mårdh1, Natalia Novikova, Ola Niklasson, Zoltan Bekassy, Lennart Skude.   

Abstract

OBJECTIVES: To determine the leukocyte esterase (LE) activity in vaginal lavage fluid of women with acute and recurrent vulvovaginal candidosis (VVC and RVVC respectively), bacterial vaginosis (BV), and in pregnant and non-pregnant women without evidence of the three conditions. Also to compare the result of LE tests in women consulting at different weeks in the cycle and trimesters of pregnancy. The LE activity was correlated to vaginal pH, number of inflammatory cells in stained vaginal smears, type of predominating vaginal bacteria and presence of yeast morphotypes.
METHODS: One hundred and thirteen women with a history of RVVC, i.e. with at least four attacks of the condition during the previous year and who had consulted with an assumed new attack of the condition, were studied. Furthermore, we studied 16 women with VVC, 15 women with BV, and 27 women attending for control of cytological abnormalities, who all presented without evidence of either vaginitis or vaginosis. Finally, 73 pregnant women were investigated. The LE activity in vaginal fluid during different weeks in the cycle of 53 of the women was measured.
RESULTS: In the non-pregnant women, an increased LE activity was found in 96, 88, 73 and 56% of those with RVVC, VVC and BV and in the non-VVC/BV cases, respectively. In 73% of pregnant women in the second trimester, and 76% of those in the third, the LE test was positive. In all groups of non-pregnant women tested, the LE activity correlated with the number of leukocytes in vaginal smears, but it did not in those who were pregnant. There was no correlation between LE activity and week in cycle. The vaginal pH showed no correlation to LE activity in any of the groups studied.
CONCLUSIONS: The use of commercial LE dipsticks has a limited value in the differential diagnosis of RVVC, VVC and BV. There is no correlation between the LE activity in vaginal secretion on one hand and vaginal pH, week in the menstrual cycle and trimester in pregnancy on the other. Women with BV often have signs of inflammation as evidenced by a positive LE test and inflammatory cells in genital smears.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839629      PMCID: PMC1852264          DOI: 10.1155/S1064744903000036

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  23 in total

1.  Screening for urinary tract infections in a gynaecological setting: validity and cost-effectiveness of reagent strips.

Authors:  A Preston; T O'Donnell; C A Phillips
Journal:  Br J Biomed Sci       Date:  1999       Impact factor: 3.829

2.  Correlation of leukocyte esterase detection by reagent strips and the presence of neutrophils: a study in BAL fluid.

Authors:  J A Jacobs; E I De Brauwer; E I Cornelissen; M Drent
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

3.  Detection of urinary leukocytes by chemstrip-l.

Authors:  J Y Gillenwater
Journal:  J Urol       Date:  1981-03       Impact factor: 7.450

4.  Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections.

Authors:  H Semeniuk; D Church
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

5.  Stability of common analytes in urine refrigerated for 24 h before automated analysis by test strips.

Authors:  P Froom; B Bieganiec; Z Ehrenrich; M Barak
Journal:  Clin Chem       Date:  2000-09       Impact factor: 8.327

6.  Characterization of women with a history of recurrent vulvovaginal candidosis.

Authors:  Natalia Novikova; Per-Anders Mårdh
Journal:  Acta Obstet Gynecol Scand       Date:  2002-11       Impact factor: 3.636

7.  High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.

Authors:  D Watson-Jones; K Mugeye; P Mayaud; L Ndeki; J Todd; F Mosha; B West; B Cleophas-Frisch; H Grosskurth; M Laga; R Hayes; D Mabey; A Buvé
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

8.  Microscopy of stained smears of vaginal secretion in the diagnosis of recurrent vulvovaginal candidosis.

Authors:  Natalia Novikova; Elena Yassievich; Per-Anders Mårdh
Journal:  Int J STD AIDS       Date:  2002-05       Impact factor: 1.359

Review 9.  Facts and myths on recurrent vulvovaginal candidosis--a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy.

Authors:  Per-Anders Mårdh; Acacio G Rodrigues; Mehmet Genç; Natalia Novikova; J Martinez-de-Oliveira; Secondo Guaschino
Journal:  Int J STD AIDS       Date:  2002-08       Impact factor: 1.359

10.  Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?

Authors:  N Novikova; A Rodrigues; P A Mårdh
Journal:  Infect Dis Obstet Gynecol       Date:  2002
View more
  3 in total

1.  Accurate 16S Absolute Quantification Sequencing Revealed Vaginal Microecological Composition and Dynamics During Mixed Vaginitis Treatment With Fufang FuRong Effervescent Suppository.

Authors:  Meng Li; Zhen Zeng; Huijun Feng; Yang Cao; Qiongqiong Zhang; Tao Lv; Xingsheng Yang; Dianrong Song; Ping Li; Lina Hu; Shangrong Fan; Ruifang An; Bei Zhang; Lei Zhang; Qinping Liao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

2.  Oral Diagnostic Methods for the Detection of Periodontal Disease.

Authors:  Liza L Ramenzoni; Marc P Lehner; Manuela E Kaufmann; Daniel Wiedemeier; Thomas Attin; Patrick R Schmidlin
Journal:  Diagnostics (Basel)       Date:  2021-03-22

3.  Association between Vaginal Micro-environment Disorder and Cervical Intraepithelial Neoplasia in a Community Based Population in China.

Authors:  Li Li; Ling Ding; Tao Gao; Yuanjing Lyu; Ming Wang; Li Song; Xiaoxue Li; Wen Gao; Yang Han; Haixia Jia; Jintao Wang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.